1. http://www.framinghamheartstudy.org/
2. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of
cardiovascular disease in chronic renal disease. Am J Kid Dis 1998;
32: 112-119
3. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD: Reverse
epidemiology of cardiovascular risk factors in maintenance dialysis
patients. Kid Int 2003; 63: 793-808
4. Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, Wu DY: Reverse
Epidemiology: A spurious hypothesis or a hardcore reality? Blood
Purif 2005; 23: 57-63
5. Kopple JD: The phenomenon of altered risk factor patterns or
reverse epidemiology in persons with advanced chronic kidney
failure. Am J Clin Nutr 2005; 81: 1257-1266
6. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr: Body
mass index and mortality in a prospective cohort of U.S. adults. N
Engl J Med 1999; 341: 1097-1105
7. Leavey SF, McCullough K, Hecking E, Goodkin D, Port FK, Young
EW: Body mass index and mortality in “healthier” as compared
with “sicker” haemodialysis patients: Results from the Dialysis
Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial
Transplant 2001; 16: 2386-2394
8. Degoulet P, Legrain M, Réach I, Aimé F, Devriés C, Rojas P, Jacobs
C: Mortality risk factors in patients treated by chronic hemodialysis.
Report of the Diaphane collaborative study. Nephron 1982; 31:
103-110
9. Leavey SF, Strawderman RL, Jones CA, Port FK, Held PJ: Simple
nutritional indicators as independent predictors of mortality in
hemodialysis patients. Am J Kidney Dis 1998; 31: 997-1006
10. Kopple JD, Zhu X, Lew NL, Lowrie EG: Body weight-for-height
relationships predict mortality in maintenance hemodialysis
patients. Kidney Int 1999; 56:1136-1148
11. Wolfe RA, Ashby VB, Daugirdas JT, Agodoa LY, Jones CA, Port
FK: Body size, dose of hemodialysis, and mortality. Am J Kidney
Dis 2000; 35: 80-88
12. Port FK, Ashby VB, Dhingra RK, Roys EC, Wolfe RA: Dialysis
dose and body mass index are strongly associated with survival in
hemodialysis patients. J Am Soc Nephrol 2002; 13: 1061-1066
13. Chazot C, Gassia JP, Di Benedetto A, Cesare S, Ponce P, Marcelli
D: Is there any survival advantage of obesity in Southern European
haemodialysis patients? Nephrol Dial Transplant 2009; 24:
2871-2876
14. Beddhu S, Pappas LM, Ramkumar N, Samore M: Effects of body
size and body composition on survival in hemodialysis patients. J
Am Soc Nephrol 2003; 14: 2366-2372
15. Kalantar-Zadeh K, Kuwae N, Wu DY, Shantouf RS, Fouque D,
Anker SD, Block G, Kopple JD: Associations of body fat and its
changes over time with quality of life and prospective mortality in
hemodialysis patients. Am J Clin Nutr 2006; 83: 202-210
16. Noori N, Kovesdy CP, Dukkipati R, Kim Y, Duong U, Bross R,
Oreopoulos A, Luna A, Benner D, Kopple JD, Kalantar-Zadeh K:
Survival predictability of lean and fat mass in men and women
undergoing maintenance hemodialysis. Am J Clin Nutr 2010; 92:
1060-1070
17. Postorino M, Marino C, Tripepi G, Zoccali C; CREDIT (Calabria
Registry of Dialysis and Transplantation) Working Group:
Abdominal obesity and all-cause and cardiovascular mortality in
end-stage renal disease. J Am Coll Cardiol 2009; 53: 1265-1272
18. Abbott KC, Oliver DK, Hurst FP, Das NP, Gao SW, Perkins RM:
Body mass index and peritoneal dialysis: “Exceptions to the
exception” in reverse epidemiology? Semin Dial 2007; 20: 561-565
19. Johnson DW, Herzig KA, Purdie DM, Chang W, Brown AM, Rigby
RJ, Campbell SB, Nicol DL, Hawley CM: Is obesity a favorable
prognostic factor in peritoneal dialysis patients? Perit Dial Int 2000;
20: 715-721
20. Abbott KC, Glanton CW, Trespalacios FC, Oliver DK, Ortiz MI,
Agodoa LY, Cruess DF, Kimmel PL: Body mass index, dialysis
modality, and survival: Analysis of the United States Renal Data
System Dialysis Morbidity and Mortality Wave II Study. Kidney Int
2004; 65: 597-605
21. McDonald SP, Collins JF, Johnson DW: Obesity is associated with
worse peritoneal dialysis outcomes in the Australia and New Zealand
patient populations. J Am Soc Nephrol 2003; 14: 2894-2901
22. Stack AG, Murthy BV, Molony DA: Survival differences between
peritoneal dialysis and hemodialysis among “large” ESRD patients
in the United States. Kidney Int 2004; 65: 2398-2408
23. Ramkumar N, Pappas LM, Beddhu S: Effect of body size and body
composition on survival in peritoneal dialysis patients. Perit Dial Int
2005; 25: 461-469
24. Kilpatrick RD, McAllister CJ, Kovesdy CP, Derose SF, Kopple JD,
Kalantar-Zadeh K: Association between serum lipids and survival
in hemodialysis patients and impact of race. J Am Soc Nephrol
2007; 18:293-303
25. Lowrie EG, Lew NL: Death risk in hemodialysis patients: The
predictive value of commonly measured variables and an evaluation
of death rate differences between facilities. Am J Kidney Dis 1990;
15: 458-482
26. Liu Y, Coresh J, Eustace JA, Longenecker JC, Jaar B, Fink NE,
Tracy RP, Powe NR, Klag MJ: Association between cholesterol
level and mortality in dialysis patients: Role of inflammation and
malnutrition. JAMA 2004; 291: 451-459
27. Habib AN, Baird BC, Leypoldt JK, Cheung AK, Goldfarb-
Rumyantzev AS: The association of lipid levels with mortality in
patients on chronic peritoneal dialysis. Nephrol Dial Transplant
2006; 21: 2881-2892
28. Lacson E Jr, Lazarus JM: The association between blood pressure
and mortality in ESRD-not different from the general population?
Semin Dial 2007; 20: 510-517
29. Koch M, Thomas B, Tschöpe W, Ritz E: Survival and predictors
of death in dialysed diabetic patients. Diabetologia 1993; 36:
1113-1117
30. Salem MM, Bower J: Hypertension in the hemodialysis population:
Any relation to one-year survival? Am J Kidney Dis 1996; 28:
737-740
31. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE:
Impact of hypertension on cardiomyopathy, morbidity and mortality
in end-stage renal disease. Kidney Int 1996; 49: 1379-1385
32. Klassen PS, Lowrie EG, Reddan DN, DeLong ER, Coladonato
JA, Szczech LA, Lazarus JM, Owen WF Jr: Association between
pulse pressure and mortality in patients undergoing maintenance
hemodialysis. JAMA 2002; 287: 1548-1555
33. Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Greenland
S, Kopple JD: Reverse epidemiology of hypertension and
cardiovascular death in the hemodialysis population: The 58th
annual fall conference and scientific sessions. Hypertension 2005;
45: 811-817
34. Li Z, Lacson E Jr, Lowrie EG, Ofsthun NJ, Kuhlmann MK, Lazarus
JM, Levin NW: The epidemiology of systolic blood pressure and
death risk in hemodialysis patients. Am J Kidney Dis 2006; 48:
606-615
35. Iseki K, Miyasato F, Tokuyama K, Nishime K, Uehara H, Shiohira
Y, Sunagawa H, Yoshihara K, Yoshi S, Toma S, Kowatari T,
Wake T, Oura T, Fukiyama K: Low diastolic blood pressure,
hypoalbuminemia and risk of death in a cohort of chronic
hemodialysis patients. Kidney Int 1997; 51: 1212-1217
36. Foley RN, Herzog CA, Collins AJ: Blood pressure and long-term
mortality in United States hemodialysis patients: USRDS Waves 3
and 4 Study. Kidney Int 2002; 62: 1784-1790
37. Udayaraj UP, Steenkamp R, Caskey FJ, Rogers C, Nitsch D, Ansell
D, Tomson CR: Blood pressure and mortality risk on peritoneal
dialysis. Am J Kidney Dis 2009; 53: 70-78
38. Beilby J, Divitini ML, Knuiman MW, Rossi E, Hung J: Comparison
of cystatin C and creatinine as predictors of cardiovascular events
in a community-based elderly population. Clin Chem 2010; 56:
799-804
39. Beddhu S, Cheung AK, Larive B, Greene T, Kaysen GA, Levey AS,
Rocco M, Sarnak M, Toto R, Eknoyan G; Hemodialysis (HEMO)
Study Group: Inflammation and inverse associations of body mass
index and serum creatinine with mortality in hemodialysis patients.
J Ren Nutr 2007; 17: 372-380
40. Avram MM, Fein PA, Bonomini L, Mittman N, Loutoby R,
Avram DK, Chattopadhyay J: Predictors of survival in continuous
ambulatory peritoneal dialysis patients: A five-year prospective
study. Perit Dial Int 1996; 16 (1): 190-194
41. Sipahioglu MH, Aybal A, Unal A, Tokgoz B, Oymak O, Utas C:
Patient and technique survival and factors affecting mortality on
peritoneal dialysis in Turkey: 12 years’ experience in a single center.
Perit Dial Int 2008; 28: 238-245
42. Wrone EM, Zehnder JL, Hornberger JM, McCann LM, Coplon NS,
Fortmann SP: An MTHFR variant, homocysteine and cardiovascular
comorbidity in renal disease. Kidney Int 2001; 60: 1106-1113
43. Kalantar-Zadeh K, Block G, Humphreys MH, McAllister CJ,
Kopple JD: A low, rather than a high, total plasma homocysteine
is an indicator of poor outcome in hemodialysis patients. J Am Soc
Nephrol 2004; 15: 442-453
44. Schwedler SB, Metzger T, Schinzel R, Wanner C: Advanced
glycation end products and mortality in hemodialysis patients.
Kidney Int 2002; 62: 301-310
45. Scholze A, Rattensperger D, Zidek W, Tepel M: Low serum leptin
predicts mortality in patients with chronic kidney disease stage 5.
Obesity (Silver Spring) 2007; 15: 1617-1622
46. Beige J, Heipmann K, Stumvoll M, Körner A, Kratzsch J:
Paradoxical role for adiponectin in chronic renal diseases? An
example of reverse epidemiology. Expert Opin Ther Targets 2009;
13: 163-173
47. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S,
Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F,
Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Ouchi N, Kihara S,
Funahashi T, Matsuzawa Y: Adiponectin, metabolic risk factors and
cardiovascular events among patients with end-stage renal disease.
J Am Soc Nephrol 2002; 13: 134-141
48. Menon V, Li L, Wang X, Greene T, Balakrishnan V, Madero M,
Pereira AA, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ:
Adiponectin and mortality in patients with chronic kidney disease. J
Am Soc Nephrol 2006; 17: 2599-2606
49. Lee SM, Lee AL, Winters TJ, Tam E, Jaleel M, Stenvinkel P,
Johnson RJ: Low serum uric acid level is a risk factor for death in
incident hemodialysis patients. Am J Nephrol 2009; 29: 79-85
50. Bautista LE, Arenas IA, Peñuela A, Martínez LX: Total plasma
homocysteine level and risk of cardiovascular disease: A metaanalysis
of prospective cohort studies. J Clin Epidemiol 2002; 55:
882-887
51. Kalantar-Zadeh K, Kopple JD: Obesity paradox in patients on
maintenance dialysis. Contrib Nephrol 2006; 151: 57-69
52. Rauchhaus M, Coats AJ, Anker SD: The endotoxin-lipoprotein
hypothesis. Lancet 2000; 356: 930-933
53. Flegal KM, Graubard BI, Williamson DF, Cooper RS: Reverse
Causation and illness-related weight loss in observational studies of
body weight and mortality. Am J Epidemiol 2011; 173: 1-9
54. Lev-Ran A: Human obesity: An evolutionary approach to
understanding our bulging waistline. Diabetes Metab Res Rev
2001; 17: 347-362
55. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE:
Hypoalbuminemia, cardiac morbidity and mortality in end-stage
renal disease. J Am Soc Nephrol 1996; 7: 728-736
56. Avram MM, Goldwasser P, Erroa M, Fein PA: Predictors of
survival in continuous ambulatory peritoneal dialysis patients:
The importance of prealbumin and other nutritional and metabolic
parameters. Am J Kidney Dis 1994; 23 91-98
57. Kawaguchi T, Tong L, Robinson BM, Sen A, Fukuhara S, Kurokawa
K, Canaud B, Lameire N, Port FK, Pisoni RL: C-Reactive Protein
and Mortality in Hemodialysis Patients: The Dialysis Outcomes and
Practice Patterns Study (DOPPS). Nephron Clin Pract 2010; 117:
167-178
58. Beberashvili I, Sinuani I, Azar A, Yasur H, Feldman L, Efrati S,
Averbukh Z, Weissgarten J: Nutritional and inflammatory status of
hemodialysis patients in relation to their body mass index. J Ren
Nutr 2009; 19: 238-247
59. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann
DL: Cytokines and cytokine receptors in advanced heart failure:
an analysis of the cytokine database from the Vesnarinone trial
(VEST). Circulation 2001; 103: 2055-2059
60. Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan
L, MacInnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman
LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman
DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton
J, Hoppin JA, Koenig KL, Lee IM, Linet MS, Park Y, Pocobelli
G, Schatzkin A, Sesso HD, Weiderpass E, Willcox BJ, Wolk A,
Zeleniuch-Jacquotte A, Willett WC, Thun MJ: Body-mass index
and mortality among 1.46 million white adults. N Engl J Med 2010;
363: 2211-2219
61. Wanner C, Krane V, März W, Olschewski M, Mann JF, Ruf G, Ritz
E; German Diabetes and Dialysis Study Investigators: Atorvastatin
in patients with type 2 diabetes mellitus undergoing hemodialysis.
N Engl J Med 2005; 353: 238-248
62. Fellström BC, Jardine AG, Schmieder RE, Holdaas H, Bannister
K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Grönhagen-Riska
C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH,
Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Suleymanlar G,
Tsakiris D, Tesar V, Todorov V, Wiecek A, Wüthrich RP, Gottlow
M, Johnsson E, Zannad F; AURORA Study Group: Rosuvastatin
and cardiovascular events in patients undergoing hemodialysis. N
Engl J Med 2009; 360: 1395-1407
63. Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC,
Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L,
Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R,
Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk
V, Fellström B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de
Zeeuw D, Grönhagen-Riska C, Dasgupta T, Lewis D, Herrington
W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen
T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill
M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R;
SHARP Investigators: The effects of lowering LDL cholesterol with
simvastatin plus ezetimibe in patients with chronic kidney disease
(Study of Heart and Renal Protection): A randomised placebocontrolled
trial. Lancet 2011; 377: 2181-2192
64. Abedin M, Tintut Y, Demer LL: Vascular calcification: Mechanisms
and clinical ramifications. Arterioscler Thromb Vasc Biol 2004; 24:
1161-1170
65. Gusbeth-Tatomir P, Covic A: Causes and consequences of increased
arterial stiffness in chronic kidney disease patients. Kidney Blood
Press Res 2007; 30: 97-107
66. Herzog CA, Mangrum JM, Passman R: Sudden cardiac death and
dialysis patients. Semin Dial 2008; 21: 300-307
67. Trivedi H, Xiang Q, Klein JP: Risk factors for non-fatal myocardial
infarction and cardiac death in incident dialysis patients. Nephrol
Dial Transplant 2009; 24: 258-266
68. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of
chronic kidney disease and decreased kidney function in the adult
US population: Third National Health and Nutrition Examination
Survey. Am J Kidney Dis 2003; 41: 1-12
69. Suleymanlar G, Utas C, Arinsoy T, Ates K, Altun B, Altiparmak
MR, Ecder T, Yilmaz ME, Camsari T, Basci A, Serdengecti K: A
population-based survey of chronic renal disease in Turkey-the
CREDIT study. Nephrol Dial Transplant 2011; 26 (6): 1862-1871
70. Yerram P, Karuparthi PR, Hesemann L, Horst J, Whaley-Connell
A: Chronic kidney disease and cardiovascular risk. J Am Soc
Hypertens 2007; 1: 178-184
71. Pernod G, Bosson JL, Golshayan D, Barro C, Forneris G, Martina
G, Bonfant G, Hurot JM, Turc-Baron C, Jouet C, Theytaz J,
Jeantet A, Wauters JP, Cordonnier D; Diamant Alpin Collaborative
Dialysis Study Group: Phenotypic and genotypic risk factors for
cardiovascular events in an incident dialysis cohort. Kidney Int
2006; 69: 1424-1430
72. WHO: Global health risks: Mortality and burden of disease
attributable to selected major risks. ISBN 978 92 4 156387
1;http://www.who.int/healthinfo/global_burden_disease/
GlobalHealthRisks_report_full.pdf
73. Kovesdy CP, Anderson JE, Kalantar-Zadeh K. Paradoxical
association between body mass index and mortality in men with
CKD not yet on dialysis. Am J Kidney Dis 2007; 49: 581-591
74. Kovesdy CP, Trivedi BK, Kalantar-Zadeh K, Anderson JE:
Association of low blood pressure with increased mortality in
patients with moderate to severe chronic kidney disease. Nephrol
Dial Transplant 2006; 21: 1257-1262
75. Chavalitdhamrong D, Danovitch GM, Bunnapradist S: Is there a
reversal of reverse epidemiology in renal transplant recipients?
Semin Dial 2007; 20: 544-548
76. Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F,
Kosiborod M, Portnay EL, Sokol SI, Bader F, Krumholz HM: The
obesity paradox: Body mass index and outcomes in patients with
heart failure. Arch Intern Med 2005; 165: 55-61
77. Marti S, Muñoz X, Rios J, Morell F, Ferrer J: Body weight and
comorbidity predict mortality in COPD patients treated with oxygen
therapy. Eur Respir J 2006; 27: 689-696
78. Escalante A, Haas RW, del Rincon I: Paradoxical effect of body
mass index on survival in rheumatoid arthritis: Role of comorbidity
and systemic inflammation. Arch Intern Med 2005; 165: 1624-1629
79. Thiebaut R, Malvy D, Marimoutou C, Davis F: Anthropometric
indices as predictors of survival in AIDS adults. Aquitaine Cohort,
France, 1985-1997. Groupe d’Epidemiologie Clinique du Sida en
Aquitaine (GECSA). Eur J Epidemiol 2000; 16: 633-639
80. Kalantar-Zadeh K, Horwich TB, Oreopoulos A, Kovesdy CP,
Younessi H, Anker SD, Morley JE: Risk factor paradox in wasting
diseases. Curr Opin Clin Nutr Metab Care 2007; 10: 433-442
81. Landi F, Onder G, Gambassi G, Pedone C, Carbonin P, Bernabei R:
Body mass index and mortality among hospitalized patients. Arch
Intern Med 2000; 160: 2641-2644
82. Onder G, Landi F, Volpato S, Fellin R, Carbonin P, Gambassi G,
Bernabei R: Serum cholesterol levels and in-hospital mortality in
the elderly. Am J Med 2003; 115: 265-271
83. Tremblay A, Bandi V: Impact of body mass index on outcomes
following critical care. Chest 2003; 123: 1202-1207
84. Oreopoulos A, Padwal R, Norris CM, Mullen JC, Pretorius V,
Kalantar-Zadeh K: Effect of obesity on short- and long-term
mortality postcoronary revascularization: A meta-analysis. Obesity
(Silver Spring) 2008; 16: 442-450
85. Stratton RJ, Bircher G, Fouque D, Stenvinkel P, de Mutsert R,
Engfer M, Elia M: Multinutrient oral supplements and tube feeding
in maintenance dialysis: A systematic review and meta-analysis.
Am J Kidney Dis 2005; 46: 387-405
86. Bossola M, Tazza L, Giungi S, Rosa F, Luciani G: Artificial
nutritional support in chronic hemodialysis patients: A narrative
review. J Ren Nutr 2010; 20: 213-223
87. Levin NW, Handelman GJ, Coresh J, Port FK, Kaysen GA: Reverse
epidemiology: A confusing, confounding, and inaccurate term.
Semin Dial 2007; 20: 586-592
88. Foley RN, Agarwal R: Hypertension is harmful to dialysis patients
and should be controlled. Semin Dial 2007; 20: 518-522
Thank you for copying data from http://www.arastirmax.com
